RTP startup backed by Eshelman hits clinical milestone By: Triangle Business Journal via Business Journals March 06, 2023 at 07:40 AM EST A startup backed by one of North Carolina's most influential venture capitalists is moving its potential cancer treatment into a clinical study. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
